Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun 24:12:695173.
doi: 10.3389/fmicb.2021.695173. eCollection 2021.

Current Status of Chikungunya in India

Collaborators
Review

Current Status of Chikungunya in India

Translational Research Consortia (TRC) for Chikungunya Virus in India. Front Microbiol. .

Abstract

Chikungunya fever (CHIKF) is an arbovirus disease caused by chikungunya virus (CHIKV), an alphavirus of Togaviridae family. Transmission follows a human-mosquito-human cycle starting with a mosquito bite. Subsequently, symptoms develop after 2-6 days of incubation, including high fever and severe arthralgia. The disease is self-limiting and usually resolve within 2 weeks. However, chronic disease can last up to several years with persistent polyarthralgia. Overlapping symptoms and common vector with dengue and malaria present many challenges for diagnosis and treatment of this disease. CHIKF was reported in India in 1963 for the first time. After a period of quiescence lasting up to 32 years, CHIKV re-emerged in India in 2005. Currently, every part of the country has become endemic for the disease with outbreaks resulting in huge economic and productivity losses. Several mutations have been identified in circulating strains of the virus resulting in better adaptations or increased fitness in the vector(s), effective transmission, and disease severity. CHIKV evolution has been a significant driver of epidemics in India, hence, the need to focus on proper surveillance, and implementation of prevention and control measure in the country. Presently, there are no licensed vaccines or antivirals available; however, India has initiated several efforts in this direction including traditional medicines. In this review, we present the current status of CHIKF in India.

Keywords: Chikungunya fever (CHIKF); chikungunya virus (CHIKV); disease resolution; epidemiology; polyarthralgia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
(A) Simplified Phylogenetic tree of all Alphaviruses generated from partial E1 envelope glycoprotein gene sequences by using the neighbor-joining program Adapted from Powers et al. (2001) (BF, Burma Forest virus; CHIKV, chikungunya virus; SF, Semliki Forest; WEE, western equine encephalitis; EEE, eastern equine encephalitis; VEE, Venezuelan equine encephalitis; NDUV, Ndumu virus; ONNV, o’nyong’nyong virus; RRV, Ross River virus). (B) Phylogenetic tree of three genotypes of chikungunya viruses.
FIGURE 2
FIGURE 2
Diagnostic matrix followed by Indian clinicians for CHIKF and related coinfections (Lee et al., 2012).
FIGURE 3
FIGURE 3
Reported chikungunya outbreaks in India and Indian Ocean Islands (IOI) shows the year of onset of chikungunya outbreaks between 1963 and 2019 in India and the change in genotype from Asian (during the 1963–1973) to ECSA (2005–2019) is sketched in black and red triangles. The data source for generating. This figure is from NVBDCP (2014-15); National Health Profile (2019); National Center for Disease Control (2020).
FIGURE 4
FIGURE 4
Year-wise CHIKF cases in India with annual rainfall and temperature (2005–2018).

References

    1. Abeyratne E., Freitas J. R., Zaid A., Mahalingam S., Taylor A. (2018). Attenuation and stability of CHIKV-NoLS, a live-attenuated chikungunya virus vaccine candidate. Vaccines 7:2. 10.3390/vaccines7010002 - DOI - PMC - PubMed
    1. Acevedo N., Waggoner J., Rodriguez M., Rivera L., Landivar J., Pinsky B., et al. (2017). Zika virus, chikungunya virus, and dengue virus in cerebrospinal fluid from adults with neurological manifestations, guayaquil, ecuador. Front. Microbiol. 8:42. - PMC - PubMed
    1. Agarwal A., Dash P. K., Singh A. K., Sharma S., Gopalan N., Rao P. V., et al. (2014). Evidence of experimental vertical transmission of emerging novel ECSA genotype of Chikungunya Virus in Aedes aegypti. PLoS Negl. Trop. Dis. 8:e2990. 10.1371/journal.pntd.0002990 - DOI - PMC - PubMed
    1. Agarwal A., Gupta S., Yadav A. K., Nema R. K., Ansari K., Biswas D. (2019). Molecular and phylogenetic analysis of Chikungunya virus in Central India during 2016 and 2017 outbreaks reveal high similarity with recent New Delhi and Bangladesh strains. Infect. Genet. Evol. 75:103940. 10.1016/j.meegid.2019.103940 - DOI - PubMed
    1. Agarwal A., Sharma A. K., Sukumaran D., Parida M., Dash P. K. (2016). Two novel epistatic mutations (E1:K211E and E2:V264A) in structural proteins of Chikungunya virus enhance fitness in Aedes aegypti. Virology 497 59–68. 10.1016/j.virol.2016.06.025 - DOI - PubMed

LinkOut - more resources